相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Causes, consequences, and therapy of tumors acidosis
Smitha R. Pillai et al.
CANCER AND METASTASIS REVIEWS (2019)
The double edge sword of fibrosis in cancer
Chelsea Chandler et al.
TRANSLATIONAL RESEARCH (2019)
Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours
Han Yao et al.
NATURE BIOMEDICAL ENGINEERING (2019)
ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer
Shigeru Hashimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches
Anita Thyagarajan et al.
CANCERS (2019)
Arf6-driven cell invasion is intrinsically linked to TRAK1-mediated mitochondrial anterograde trafficking to avoid oxidative catastrophe
Yasuhito Onodera et al.
NATURE COMMUNICATIONS (2018)
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
Bertrand Allard et al.
IMMUNOLOGICAL REVIEWS (2017)
Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy
Hong Jiang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
P53-and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance
Ari Hashimoto et al.
JOURNAL OF CELL BIOLOGY (2016)
Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression
Hanane Laklai et al.
NATURE MEDICINE (2016)
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
Hong Jiang et al.
NATURE MEDICINE (2016)
Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer
Shigeru Hashimoto et al.
NATURE COMMUNICATIONS (2016)
ZEB1 induces EPB41L5 in the cancer mesenchymal program that drives ARF6-based invasion, metastasis and drug resistance
A. Hashimoto et al.
ONCOGENESIS (2016)
Pancreatic cancer biology and genetics from an evolutionary perspective
Alvin Makohon-Moore et al.
NATURE REVIEWS CANCER (2016)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
The prognostic value of stroma in pancreatic cancer in patients receiving adjuvant therapy
Katherine M. Bever et al.
HPB (2015)
α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study
M. Sinn et al.
BRITISH JOURNAL OF CANCER (2014)
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
Berna C. Oezdemir et al.
CANCER CELL (2014)
Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling
Susann Weissmueller et al.
CELL (2014)
High level expression of AMAP1 protein correlates with poor prognosis and survival after surgery of head and neck squamous cell carcinoma patients
Hiroki Sato et al.
CELL COMMUNICATION AND SIGNALING (2014)
Rab5c promotes AMAP1-PRKD2 complex formation to enhance β1 integrin recycling in EGF-induced cancer invasion
Yasuhito Onodera et al.
JOURNAL OF CELL BIOLOGY (2012)
Three-Dimensional Collagen I Promotes Gemcitabine Resistance in Pancreatic Cancer through MT1-MMP-Mediated Expression of HMGA2
Surabhi Dangi-Garimella et al.
CANCER RESEARCH (2011)
Engagement of Overexpressed Her2 with GEP100 Induces Autonomous Invasive Activities and Provides a Biomarker for Metastases of Lung Adenocarcinoma
Toshi Menju et al.
PLOS ONE (2011)
The EGFR-GEP100-Arf6-AMAP1 Signaling Pathway Specific to Breast Cancer Invasion and Metastasis†
Hisataka Sabe et al.
TRAFFIC (2009)
The Activated Stroma Index Is a Novel and Independent Prognostic Marker in Pancreatic Ductal Adenocarcinoma
Mert Erkan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Focal adhesion kinase as a regulator of cell tension in the progression of cancer
Robert W. Tilghman et al.
SEMINARS IN CANCER BIOLOGY (2008)
GeP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion
Masaki Morishige et al.
NATURE CELL BIOLOGY (2008)
Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer
Takeo Nomi et al.
CLINICAL CANCER RESEARCH (2007)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities
Y Onodera et al.
EMBO JOURNAL (2005)
Requirement for Arf6 in breast cancer invasive activities
S Hashimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma
AJ Aguirre et al.
GENES & DEVELOPMENT (2003)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
SR Hingorani et al.
CANCER CELL (2003)
Requirement for Arf6 in cell adhesion, migration, and cancer cell invasion
H Sabe
JOURNAL OF BIOCHEMISTRY (2003)
Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context
C Guerra et al.
CANCER CELL (2003)
分享论文
